REF cells transformed by oncogenes E1A and cHa-ras reveal high and constitutive DNA-binding activity of AP-1 factor lacking in c-Fos protein. Consistently, the transcription of c-fos gene has been found to be downregulated. To elucidate the mechanisms of c-fos downregulation in E1A+cHa-ras transformants, we studied the levels of activity of ERK, JNK/SAPK and p38 kinases and phosphorylation state of Elk-1 transcription factor involved in regulation of c-fos gene. Using two approaches, Western blot analysis with phospho-speci®c antibodies to MAP kinases and in vitro kinase assay with speci®c substrates, we show here that ectopic expression of E1A and ras oncogenes leads to a sustained activation of ERK and p38 kinases, whereas JNK/SAPK kinase activity is similar to that in nontransformed REF52 cells. Due to sustained activity of the MAP kinase cascades, Elk-1 transcription factor is being phosphorylated even in serum-starved E1A+cHa-ras cells; moreover, serum does not additionally increase phosphorylation of Elk-1, which is predominant TCF protein bound to SRE region of c-fos gene promoter in these cells. Although the amount of ternary complexes SRE/SRF/TCF estimated by EMSA was similar both in serum-starved and serum-stimulated transformed cells, serum addition still caused a modest activation of c-fos gene transcription at the level of 20% to normal REF cells. In attempt to determine how serum caused the stimulatory eect, we found that PD98059, an inhibitor of MEK/ERK kinase cascade, completely suppressed serum-induced c-fos transcription both in REF and E1A+cHa-ras cells, implicating the ERK as primary kinase for c-fos transcription in these cells. In contrast, SB203580, an inhibitor of p38 kinase, augmented noticeably serum-stimulated transcription of c-fos gene in REF cells, implying the involvement of p38 kinase in negative regulation of c-fos. Furthermore, sodium butyrate, an inhibitor of histone deacetylase activity, was capable of activating c-fos transcription both in serum-stimulated and even in serum-starved E1A+cHa-ras cells. Conversely, serum-starved REF cells fail to respond to sodium butyrate treatment by c-fos activation con®rming necessity of prior Elk-1 phosphorylation. Taken together, these data suggest that downregulation of c-fos in E1A+cHa-ras cells seems to occur due to a maintenance of a refractory state that arises in normal REF cells after serum-stimulation. The refractory state of c-fos in E1A+cHa-ras cells is likely a consequence of Ras-induced sustained activation of MAPK (ERK) cascade and persistent phosphorylation of TCF (Elk-1) bound to SRE. Combination of these events eventually does contribute to formation of an inactive chromatin structure at c-fos promoter mediated through recruitment of histone deacetylase activity.
Introduction
We have previously shown that transformation of primary rat embryo ®broblasts (REF) by a combination of oncogenes E1Aad5 and cHa-ras leads to high and constitutive AP-1 DNA-binding activity and to alteration of the AP-1 complex composition . However, transcription of c-fos and c-jun genes, the products of which contribute to formation of AP-1 complexes, is aected dierently in E1A+cHa-ras-transformed cells: c-fos transcription is downregulated, whereas c-jun is transcribed at elevated albeit unregulated level. To this end, we showed the following alterations in AP-1 composition: c-Fos/c-Jun dimers are replaced by Fra-1/c-Jun and c-Jun/ATF-2 dimers (Pospelova et al., 1996 . Similar changes of the AP-1 composition were found in cells transformed by single Ras (Mechta et al., 1997; Kessler et al., 1999) ; this was not the case in E1A-expressing cells (Pospelova et al., 1996) . The observed changes are supposed to be linked with cell transformation induced by various oncogenes (Yu et al., 1993) .
It has been shown that promoters of c-fos and cjun genes are permanently occupied by proteins regardless of growth factor deprivation or stimulation (Herrera et al., 1989; Rozek and Pfeifer, 1995) . Therefore, transcription activation of c-fos and c-jun is likely to be determined by phosphorylation of preexisting factors mediated through dierent MAP kinase cascades (Clarke et al., 1998) . Since Rasexpressing cells frequently reveal elevated activity of MAP kinase cascades (in particular, ERK) (Silberman et al., 1997; Amundadottir and Leder, 1998) , the mechanisms of c-fos downregulation remain still obscure (Konig et al., 1989; Janknecht et al., 1993; Yates et al., 1999) .
In normal cells, serum stimulation of c-fos is mediated through a SRE region containing a dyad symmetry element (DSE) for binding SRF and a contiguous Ets motif for binding ternary complex factors (TCFs) (Hill et al., 1995) . There is a family of TCFs including Elk-1, Sap-1, Sap-2/Net which are phosphorylated by ERK, JNK/SAPK and p38 kinases in response to growth factors and stress-inducing agents (Whitmarsh et al., 1995; Giovane et al., 1997; Clarke et al., 1998; Yang et al., 1998; Cruzalegui et al., 1999) . If Elk-1 is a positively acting transcription factor, Net is a transcription repressor that is switched to a positive regulator by the Ras signal (Criqui-Filipe et al., 1999) . By using stable integration of fos-CAT reporters with mutations at various binding sites for SRF, TCF, CREB, we have recently shown that c-fos downregulation is likely to be mediated through the SRE region .
To understand the mechanisms of c-fos downregulation in E1A+cHa-ras cells, we studied the levels of basal and serum-inducible activity of ERK, JNK, and p38 kinases, the phosphorylation status of Elk-1, the eects of MAP kinase inhibitors (PD98059 and SB203580) and histone deacetylase inhibitor (sodium butyrate) on transcription of endogenous cfos gene. The data obtained are interpreted to mean that the c-fos downregulation in E1A+cHa-rastransformed cells is a result of formation of inactive chromatin structure in the promoter. Among events contributing to this, we can indicate the sustained activity of ERK kinase cascade followed by persistent phosphorylation of Elk-1 transcription factor that, in turn, by yet unknown mechanism recruits a histone deacetylase activity to a nucleosome located just downstream of SRE in the c-fos promoter. Accordingly, sodium butyrate, an inhibitor of histone deacetylase activity, is capable of activating the c-fos transcription in serum-starved E1A+cHa-ras as well as in serum-stimulated cells. Importantly, the MEK/ ERK kinase inhibitor PD98059 completely suppressed serum-stimulated transcription of c-fos in REF and E1A+cHa-ras cells implying that both activation and following downregulation of c-fos is mainly mediated through eects produced by the ERK kinase cascade. In contrast, p38 kinase inhibitor SB203580 augmented serum-stimulated c-fos transcription in REF cells suggesting a cross talk between ERK and p38 kinase cascades in c-fos repression. The question of whether c-fos downregulation is a direct result of ERK/p38 kinase activation or this phenomenon is to be considered in the context of cell transformation requires further studies.
Results
Elk-1 is predominant TCF protein of ternary complexes bound to SRE of c-fos gene promoter Downregulation of c-fos transcription in E1A+cHa-ras cells can be caused by various mechanisms, in particular by a substitution of active TCFs on repressors such as Net-b (Giovane et al., 1997) . Therefore, we ®rst performed Western blot analysis of Elk-1, Sap-1, Net, and Net-b proteins isolated from REF and E1A+cHa-ras cells. Accordingly, the content of Elk-1, Sap-1, and Net proteins was nearly the same both in serum-starved and serum-stimulated normal and transformed cells (data not shown). Regarding Net-b that is a natural potential repressor of c-fos transcription (Giovane et al., 1997) , it is not detected in normal and transformed cells with the used antibody. Thus, if repressors (Net-b) replace activator TCFs like Elk-1, this is out of sensitivity of used analysis.
To analyse which TCF protein is bound to the SRE of c-fos promoter, we used electrophoretic-mobilityshift-assay (EMSA) with SRE oligonucleotide as a probe. This method is adequate to distinguish between dimeric SRF/SRF complexes and ternary complexes SRF/SRF/TCF (TC) (Treisman, 1994; Whitmarsh et al., 1995) , particularly if this method is supplemented with antibodies that bind to and change the mobility of ternary complexes. Nuclear extracts were preliminary incubated either with antisera raised to Elk-1, Sap-1, Net, Net-b proteins or with anity-puri®ed antibodies to Elk-1 and Sap-1. After addition of labeled probe, the formed complexes were resolved in 4% polyacrylamide gel. Data presented in Figure 1a show that the only Elk-1-speci®c antisera or anitypuri®ed antibody to Elk-1 caused a reduction of the speci®c ternary complexes (lanes 2 and 3, TC-marked band). The same results have been obtained with nuclear extracts from serum-starved E1A+cHa-ras cells (data not shown) indicating that the SRE oligonucleotide binds to ternary complexes containing Elk-1 as predominant TCF independently on the conditions of cell culturing: serum-starvation or serum-stimulation. In the given experiments, nonimmune rabbit serum (NRS) was used as a control for rabbit antibodies to TCF proteins. NRS caused formation of non-speci®c complexes indicated in Figure 1a by asterisk (lane 7). Antisera to TCF proteins gave similar non-speci®c bands albeit with a lesser intensity (lanes 2, 4 ± 6), the mobility of the nonspeci®c bands being lower than the mobility of TC complexes.
Serum-stimulation does not increase the amount of ternary complexes in E1A+cHa-ras cells
It has been shown that Elk-1 acquires a positive regulation of c-fos promoter after its phosphorylation conducted by various MAP kinases (ERK, JNK/SAPK, p38) on speci®c serine and threonine residues located in the transactivating C-terminal domain (TAD) (Yang et al., 1998 Cruzalegui et al., 1999) . As the amount of ternary complexes containing phosphorylated TCFs accumulates upon growth factor stimulation of normal cells, we applied this approach to see whether serum-stimulation leads to TC accumulation in E1A+cHa-ras cells. Gel retardation assay performed with nuclear extracts of serum-starved and serum-stimulated E1A+cHa-ras transformants did not demonstrate any changes neither in the amount nor in mobility of the ternary complexes ( Figure 1b, lanes 3, 4) . We compared our cells with another transformed cell line, where regulated transcription of c-fos has been demonstrated (Wang and Prywes, 2000) ; indeed, in HeLa cells serum signi®cantly stimulated accumulation of ternary complexes (Figure 1b, lanes 5, 6) . Phosphorylated ternary complexes were also accumulated in serum-stimulated REF52 cells (Figure 1b, lanes 1,  2) . Consistent data we obtained by Western blot analysis with antibodies speci®c for Elk-1 phosphoserine-383 to estimate the content of phospho-Elk-1 protein in serum-stimulated E1A+cHa-ras, HeLa and REF52 cells (Figure 1c) .
While no changes could be seen in E1A+cHa-ras cells stimulated for 30 min (middle panel), 30-min serum stimulation markedly led to accumulation of pElk-1 in REF52 (left panel) and HeLa (right panel) cells (Figure 1c , 30 min). Stimulation with serum for 120 min led to a decrease of pElk-1 in REF52 and HeLa cells, but not in E1A+cHa-ras cells. The content of Elk-1 factor itself was not changed at dierent serum conditions for all three cell lines as shown by control Western blot experiments with anity-puri®ed antibody to Elk-1 protein (Figure 1c , bottom panels). Thus, serum stimulation does not increase accumulation of ternary complexes in E1A+cHa-ras cells (Figure 1b ) that correlates with its inability to stimulate phosphorylation of Elk-1 protein at Ser-383 (Figure 1c) . 3, 5 ) and serum-stimulated for 30 min (lanes 2, 4, 6) REF52 (lanes 1, 2), E1A+ras (lanes 3, 4) and HeLa cells (lanes 5, 6) were incubated with the SRE probe. TC ± ternary complexes, SRF ± dimeric complexes, NS ± non-speci®c complexes. (c) Serum-stimulation does not increase the amount of phosphorylated Elk-1 factor in E1A+cHa-ras cells. Proteins from serum-starved and serum-stimulated for 30 and 120 min REF52, E1A+ras and HeLa cells were resolved in 10% polyacrylamide gel, blotted and visualized by antibodies to pElk-1 (top panels) or Elk-1 (bottom panels) E1A+cHa-ras transformants reveal elevated amount of non-phosphorylated forms of ERK, JNK/SAPK and p38 kinases and phosphorylated forms of ERK and p38 kinases As Elk-1 protein phosphorylation is mediated through various MAP kinase cascades (ERK, JNK/SAPK, and p38) at its C-terminal TAD, ®rstly, we estimated the content of ERK, JNK, and p38 kinases in nontransformed REF52 and E1A+cHa-ras transformed cells. Cell lysates from serum-starved and serumstimulated cells were used for a Western blot analysis with antibodies to non-phosphorylated kinases. The obtained results showed that the amount of all investigated kinases was markedly higher in transformed cells and barely changed in response to serum stimulation ( Figure 2a ). The accumulation of ERK, JNK and p38 kinases in E1A+cHa-ras transformed cells corroborates with the increase of various cellcycle regulating proteins observed earlier in E1A-expressing cells (Nakajima et al., 1998; Bulavin et al., 1999) . At that, it does not mean that all accumulated kinases are in active form and are able to phosphorylate the appropriate targets (see below and Discussion).
In order to evaluate the phosphorylation status of ERK, JNK/SAPK and p38 kinases in E1A+cHa-ras cells, we used antibodies speci®c to phosphorylated forms of these kinases. Western blot analysis presented in Figure 2b show that in non-transformed REF52 cells the level of phosphorylated ERK1 depends on the serum conditions: the amount of pERKs is very low in serum-starved REF52 cells but it increased quickly upon serum-stimulation for 10 and 20 min. In contrast, serum-starved and serum-stimulated E1A+cHa-ras cells revealed elevated level of pERKs comparable to that in stimulated REF52 cells (Figure 2b, upper panel) . This implies the sustained activation of Ras/ Raf/MEK/ERK kinase cascade in E1A+cHa-ras cells.
As for the phosphorylated form of JNK kinase, the amount of this kinase form was found to be similar in E1A+cHa-ras transformants and REF52 cells where it could be weakly stimulated by serum (Figure 2b , middle). However in E1A+cHa-ras cells serum had no detectable eect on the phosphorylation of the JNK kinase (Figure 2b, middle) . Concerning the level of phospho-p38 kinase, the expression of E1A and ras oncogenes led to a sustained phosphorylation of this kinase. Thus, general conclusion is that the transformation of REF cells by oncogenes E1A and ras is Figure 2 The content of non-phosphorylated and phosphorylated ERK, JNK and p38 kinases in non-transformed REF52 and transformed E1A+ras cells. Proteins from starved REF52 or E1A+ras cells (7) and serum-stimulated for 10 or 20 min cells were resolved in 10% gel, blotted and visualized by antibodies to non-phosphorylated (a) and phosphorylated (b) ERK1, JNK and p38 kinases accompanied by a persistent activation of ERK and p38 kinases.
E1A+cHa-ras cells demonstrate elevated activity of ERK and p38 kinases
Demonstration of sustained phosphorylation of ERK and p38 kinases as assessed by phospho-speci®c antibodies in Western blot does not necessarily mean their activity towards target proteins, in particular, in relation to TCF proteins that are involved in regulation of c-fos transcription (Whitmarsh et al., 1997) . To evaluate the real activity of ERK, JNK and p38 kinases towards speci®c substrates, we performed an in vitro kinase assay with GST-Elk1-C, GST-Jun-N, GST-ATF2-N and GST-MEF2A as speci®c substrates for ERK, JNK and p38 kinases.
To analyse ERK kinase activity in exponentially growing REF and E1A+cHa-ras cells (10% FCS), cell extracts were immunoprecipitated with ERK-speci®c antibodies. The IP-complexes were bound to Protein A-Sepharose beads and used for in vitro kinase assay with GST-Elk1-C as substrate ( Figure 3a , panel 1). To bind and analyse JNK kinase activity, GST-Jun-N and GST-ATF2-N fusion proteins were incubated with cell lysates, for p38 kinase ± GST-MEF2A fusion protein.
The washed complexes containing GST-fusion substrates served as source of the bound kinases for in vitro phosphorylation (solid assay).
Data presented in Figure 3a show that in exponentially growing cells (10% FSC) the level of ERK, JNK and p38 kinase activity was higher in E1A+cHa-ras transformants (row E) than in normal REF cells (row R). However, if activity of JNK and p38 kinases was barely detected in REF cells growing in 10% of FCS (panels 2 ± 4), the ERK activity had a noticeable level in the REF cells (panel 1). To be convinced in substrate-speci®city of MEF2A for p38 kinase, we used SB203580, an inhibitor of p38 kinase, that as expected suppressed phosphorylation of GST-MEF2A (panel 4).
To study the capability of serum to stimulate the activity of ERK, JNK and p38 kinases in E1A+cHa-ras transformants, extracts from serum-starved cells and cells serum-stimulated for 10 and 30 min were immunoprecipitated with kinase-speci®c antibodies followed by in vitro kinase assay. According to these data, serum signi®cantly stimulated ERK kinase activity in starving REF52 cells (Figure 3b , IP-ERK). However the ERK kinase activity was high in serum-starved E1A+cHa-ras cells and it even increased upon serum stimulation (Figure 3b ) that correlated with the lack of an increase of the amount of ternary complexes demonstrated in gel retardation assay and the content of phospho-ERK (see Figures  1b and 2b) .
Activity JNK kinase can be transiently stimulated by serum in non-transformed REF52 cells (10 min) followed by a decrease at 30 min; but both serumstarved and serum-stimulated E1A+cHa-ras cells show the non-regulatable JNK activity that is very similar to the level in REF52 cells (Figure 3b , IP-JNK). As for the p38 kinase activity, it can also be stimulated by serum in REF52 cells (Figure 3b , IP-p38, 10 min); however, the level of p38 kinase activity is markedly higher in E1A+cHa-ras cells and it does not increase upon serum stimulation (Figure 3b, IP-p38 ). Therefore, one may conclude that serum did not in¯uence the activity of JNK, the level of which was similar in REF52 and E1A+cHa-ras cells. The ERK and p38 kinase activities were higher in serum-starved E1A+cHa-ras cells in comparison with starved REF52 cells.
We also studied serum-inducibility of the kinases bound to Elk-1. For this, cell lysates from serumstarved and serum-stimulated REF and E1A+cHa-ras cells were immunoprecipitated with antibody to Elk-1, then the immunocomplexes adsorbed on Protein ASepharose beads were used for in vitro kinase assay with GST-Elk1-C fusion protein as substrate comprising the C-terminal transactivating domain of Elk-1 (Figure 3c ). These experiments showed that, if in REF cells Elk1-associated kinase activity is being regulated by serum from nearly zero to a high level (lanes 1 and 2), in E1A+cHa-ras cells one can see high Elk1-bound kinase activity both in starved and serum-stimulated cells (lanes 3 and 4).
Transcription factor Elk-1 is predominantly phosphorylated through ERK kinase cascade in E1A+cHa-ras cells
We showed high levels of phosphorylated ERK and p38 kinases in transformed cells irrespective of serum-starvation or stimulation (Figures 2b and  3b ). This fact allows suggesting that Elk-1 or other Ets-family transcription factors permanently bound at the SRE of c-fos promoter can be constitutively phosphorylated through ERK/p38 kinase pathways. To see the role of ERK and p38 kinases in phosphorylation of Elk-1 TAD in E1A+cHa-ras cells, we used speci®c inhibitors: for MEK/ERK pathway ± PD98059 and for p38 kinase ± SB203580. Starved REF52 and E1A+cHa-ras cells were treated with indicated inhibitors (see legend to Figure 3d ), then stimulated by serum for 20 min. Cell lysates were incubated with GST-Elk1-C, the complexes were adsorbed on Glutathione-Sepharose beads and used for in vitro kinase assay with 32 P-g-ATP. According to these data, MEK inhibitor PD98059 greatly reduced serum-induced Elk1-associated kinase activity both in E1A+cHa-ras transformants and REF52 cells (Figure 3d , compare lanes 2 and 4), whereas p38 kinase inhibitor SB203580 even stimulated phosphorylation of GST-Elk1-C (Figure 3d, lane 3) . Combined treatment with PD98059 and SB203580 inhibitors suppressed as MEK inhibitor alone (data not shown), implying that the contribution of JNK kinase in phosphorylation of Elk-1 was very low. It has been recently reported that SB203580 is able to increase ERK and JNK activity in papilloma-expressing murine kerati-nocytes (Rosenberger et al., 1999a,b) . In these cells, inhibition of p38 kinase was shown to augment transcription of immediate early genes (c-fos, c-jun) induced by EGF. Also in pancreatic cancer cells PANC-1 a blockage of p38 kinase by SB203580 induced markedly the MEK/ERK kinase pathway (Ding and Adrian, 2001 ). Here we obtained results that ERK kinase cascade was predominant pathway of phosphorylating the TCF in E1A+cHa-ras transformed cells. Taken together, this data indicate that sustained ERK activity in these transformed cells is still not sucient condition per se to maintain transcription of c-fos gene on an adequate level . This allows the suggestion that other mechanisms, including, for example, the formation of inactive chromatin structure at c-fos promoter are likely to be involved in negative regulation of c-fos gene transcription. ± 4) . DMSO, a solvent of these inhibitors, was added to control starved and stimulated cells (lanes 1 and 2) . The cell extracts were incubated with GST-Elk-C substrate to bind Elk-1-speci®c kinases, and the bound complexes were used to phosphorylate the same substrate in the in vitro kinase assay
Attenuation of c-fos transcription in E1A+cHa-ras cells as compared with normal cells
Firstly, we have checked the levels of c-fos transcription in REF and E1A+cHa-ras under dierent cell growing conditions. As expected, serum-starved normal REF cells did not reveal c-fos transcription (Figure 4a , lane 1); in spite of sustained ERK kinase activity in serum-starved E1A+cHa-ras cells (Figures 2 and 3 ) these transformed cells demonstrate low-intensity fosspeci®c band (356 bp) (Figure 4, lane 7) . Under serum stimulation, the transcription of c-fos gene reaches a peak at 45 min (Figure 4a , lanes 3 and 9) followed by a decline with a subsequent signi®cant reduction at 120 min (a refractory state) (lanes 5 and 11). Although a pattern of c-fos activation in E1A+cHa-ras cells was 1, 2, 7, 8) . Lanes 1 and 7 ± control serum-starved cells, in lanes 2 ± 6 and 8 ± 12 cells were stimulated by 10% FCS for 45 min until cell harvesting found to follow similar kinetics as for REF cells, the maximal transcription value being less several-fold. This con®rms our data obtained with Northern-blot hybridization (Pospelova et al., 1996 and the results obtained in other studies on Ras-expressing cells (Yu et al., 1993; Kessler et al., 1999) . Thus, the serum stimulation of E1A+cHa-ras transformants failed to achieve the level of transcription observed in normal serum-stimulated REF cells implying that the c-fos downregulation was provided by yet additional mechanisms in E1A+cHa-ras cells.
Secondly, we used speci®c inhibitor of ERK kinase, PD98059 to elucidate whether serum-stimulated activation of c-fos transcription was mediated through MEK/ERK kinase cascade (Figure 4c ). In fact, the MEK/ERK inhibitor PD98059 completely inhibited cfos transcription at 50 mM concentration in REF cells (Figure 4c , lane 6) and caused a similar eect in E1A+cHa-ras cells (lanes 11 and 12). These data are interpreted to mean that ERK kinase cascade is predominant pathway for serum-mediated activation of c-fos gene transcription both in normal REF and transformed E1A+cHa-ras cells. In contrast, p38 kinase inhibitor SB203580 did not display any inhibitory eect on serum-stimulated c-fos transcription neither in REF nor in E1A+cHa-ras cells (Figure 4c, lanes 3, 4 and 9, 10) . Moreover, SB203580 inhibitor manifested an activatory eect in normal REF cells. Therefore, the p38 kinase is supposed to render rather negative action on MEK/ ERK either through activation of a phosphatase that speci®cally dephosphorylates MEK/ERK or through a direct association with ERK kinases (Zhang et al., 2001) . It has been recently shown that p38 kinase might be involved in activation of protein phosphatases 1 and 2A that are capable of inhibiting MEK/ ERK kinase cascade; therefore inhibition of p38 kinase activity can increase the MEK/ERK kinase activity (Westermarck et al., 2001) . This is corroborated by early data that PP2A phosphatase inhibitor okadaic acid augments the serum-stimulated transcription of c-fos (Schonthal et al., 1991; Zinck et al., 1993) . To check our cell system, we pre-treated serum-starved REF and E1A+cHa-ras cells with okadaic acid (OA), then stimulated by serum and performed RT ± PCR assay of c-fos transcripts (Figure 4b) lanes 3 and 4) . However, okadaic acid activated c-fos transcription both in serum-stimulated and also in serum-starved E1A+cHa-ras transformants (Figure 4b, lanes 7 and 8) . This con®rmed that serum-starved E1A+cHa-ras cells have already contained pre-phosphorylated Elk-1 or other TCF proteins, and the phosphatase inhibitor seems to shift the equilibrium of phosphorylation/dephosphorylation and promoted additional accumulation of the phosphorylated forms.
Sodium butyrate, a histone deacetylase inhibitor, activates transcription of c-fos gene promoter in serum-starved E1A+cHa-ras cells Elevated activity of MAP-kinase cascades (ERK and p38) in E1A+cHa-ras cells did not lead to high level of c-fos transcription. Therefore, to see how chromatin structure was involved in c-fos downregulation, we used a RT ± PCR approach to investigate c-fos transcription in E1A+cHa-ras cells after pre-treatment of serum-starved cells with sodium butyrate, an inhibitor of histone deacetylase activity (Yoshida et al., 1995) . We treated serum-starved REF and E1A+cHa-ras cells for 6 h with 10 mM of sodium butyrate, then cells were stimulated with serum for 45 and 120 min. Data presented in Figure 4a show that sodium butyrate induces c-fos transcription in serumstarved E1A+cHa-ras cells but not in serum-starved REF cells (lanes 2 and 8) . The activation eect of sodium butyrate was signi®cant at serum stimulation of E1A+cHa-ras cells for 45 min (maximal transcription level) and it was comparable with serum eect in normal REF cells (Figure 4a , lanes 3 and 4, left panel for REF cells and lanes 9 and 10, right panel for E1A+cHa-ras cells). The data obtained con®rm a suggestion that c-fos repression in E1A+cHa-ras cells, among other reasons, depends on the histone deacetylase activity associated with the c-fos promoter-located nucleosome (Herrera et al., 1997) . Interestingly, downregulation of c-fos transcription seems to be selective, since sodium butyrate unable to activate the transcription of other AP-1-regulated genes, c-jun and collagenase I (manuscript in preparation).
A question arises why sustained activity of ERK kinase in E1A+cHa-ras cells does not lead to elevated c-fos transcription. This point can be cleared up if to suggest that permanently phosphorylated Elk-1 becomes associated with a histone deacetylase to induce formation of inactive chromatin structure at the c-fos promoter. To check this question, we performed immunoprecipitation assay with antibodies to HAtagged Elk-1 transcription factor and probed the immunoprecipitates with antibodies to HDAC1 protein ( Figure 5 ). Cells were serum-starved and then stimulated with serum for 30 and 120 min. Cell extracts from nontransformed REF52 and E1A+cHa-ras transformed cells were used to immunoprecipitate with HA-speci®c antibodies. The data show that serum-starved normal REF52 cells have the larger amount of Elk1-bound HDAC1, while at 30 min of stimulation the binding is decreased followed by further increase of Elk-1/HDAC1 association after serum stimulation for 120 min ( Figure  5, upper panel) . No such signi®cant changes in Elk-1/ HDAC1 association can be seen in E1A+cHa-ras cells at 30-min stimulation ( Figure 5, bottom panel) .
Discussion
Transformation of rat primary ®broblasts by oncogenes E1A and cHa-ras can lead to deregulation of AP-1 factor activity through excitation of various MAP kinase pathways. Indeed, as PD98059, an inhibitor of MEK/ERK pathway, almost completely suppressed serum-induced c-fos gene transcription, the ERK kinase can be considered as a principal kinase for its activation. Consistently, the Elk-1 transcription factor is highly phosphorylated even in serum-starved E1A+cHa-ras cells (Figures 2b and 3b) implying that the sustained activity of ERK kinase targets Elk-1 factor. The p38 kinase is likely to be less involved in phosphorylation of SRE-bound TCF in E1A+cHa-ras cells, because SB203580 inhibitor did not suppress the c-fos transcription (Figure 4c) .
The capability of serum growth factors activate the transcription of immediate early genes c-fos and c-jun can depend in part on how the JNK or p38 kinases do modulate high activity of Ras/Raf/MEK/ERK pathway in E1A+cHa-ras cells. The results with SB203580, an inhibitor of p38 kinase, evidenced that pre-treatment with SB203580 increased serum-induced c-fos transcription in normal REF cells and to a lesser extent in E1A+cHa-ras cells implying a rather negative in¯uence of p38 kinase on ERK-dependent activation of Elk-1. There are recent data that SB203580 treatment does result in marked induction of MEK and ERK phosphorylation and activation of MEK/ERK pathway (Singh et al., 1999; Ding and Adrian, 2001 ). On the other hand, it is known that p38a kinase may interact physically with ERK1/2 kinases, thereby blocking sterically phosphorylation of ERK kinases by MEK1 (Zhang et al., 2001) . Also, we have unpublished results on transient transfection of various GAL-Elk-1 plasmids into REF52 and E1A+cHa-ras cells treated with the MEK/ERK and p38 kinase inhibitors. In these experiments we received consistent data with those presented in Figures 3d and 4c : serum-induced transactivation by Gal-Elk-1 was suppressed by MEK inhibitor PD98059 (ERK kinase cascade) and was stimulated by SB203580 (p38 kinase inhibitor) (manuscript in preparation).
E1A+cHa-ras cells express oncogenic Ras that is capable of activating directly Ras/Raf/MEK/ERK kinase cascade (Gille and Downward, 1999) , but indirectly Ras can activate the JNK and p38 kinase cascades (Hibi et al., 1993; Westwick et al., 1994) . It is known that the activity of JNK/SAPK and p38 kinases is stimulated in response to stress factors and genotoxic agents ± UV light, hypoxia, in¯ammation and cytokines (van Dam et al., 1998) , whereas ERK cascade kinase is activated by growth factors and mitogens (Treisman, 1996) . Therefore, in exponentially growing normal ®broblast cells the level of JNK/SAPK and p38 kinases activity is shown to be low and it changes little upon serum and EGF treatment (Hazzalin et al., 1997) .
There are data that oncogenic transformation can be accompanied by both activation of JNK1 and JNK2 kinases (Hibi et al., 1993; Xie and Herschman, 1995; Raitano et al., 1995) and by the absence of such activation (Amundadottir and Leder, 1998) . Analysis of ERK and JNK kinase activity showed that dierent oncogenes might use certain kinase cascades for transformation. Thus far, neu, v-Ha-ras and c-myc requires activation of ERK pathway to transform mammary cells, whereas the ERK kinases were shown to be slightly activated in TGFa-induced tumors (Amundadottir and Leder, 1998) . Importantly, inhibition of MAP/ERK-kinase activity by introduction of a dominant-negative ERK2 mutant suppressed AP-1 transactivation and transformation (Watts et al., 1998) . From the other hand, ectopic expression of constitutive MEK/ERK kinases led to full transformation of NIH3T3 cells (Cowley et al., 1994) . Thus, at present, a relationship between ERK activation and cell transformation seems to be clearer.
As for the role of JNK and p38 in cell transformation, the involvement of these kinases is less clear. Transient expression of Ras activates all cascades: ERK, JNK and p38 and induces transcription of immediate early genes c-fos, c-jun and NF-kB as well (Graham et al., 1999) . However, upon establishing the transformed state by E1A plus cHa-ras oncogenes, interplay between dierent kinase pathways and clonal selection may provide an advantage for the certain kinase cascades thereby restricting the transcription of speci®c genes such as c-fos.
Interestingly, the expression level of non-phosphorylated ERK, JNK and p38 kinases was found to be signi®cantly higher in E1A+cHa-ras cells in comparison with REF or REF52 cells (Figure 2a ). However, a proportional increase of the respective phosphorylated kinases is detected only in case of p38 kinase ( Figure  2b ). Importantly, that absolute amount of pERK kinase in E1A+cHa-ras cells is high irrespective of serum. Worthwhile to mention that in most analysed myeloid leukemia (AML) cells, while the non-phosphorylated ERK-2 kinase was found to be accumulated, only some of the cell lines revealed elevated amount of p-ERK2 (Morgan et al., 2001) . Moreover, among cells heavily stained with anti-ERK-2 and anti-MEK-1, only 1% to 5% showed strong nuclear Figure 5 Elk-1 factor associates with HDAC1. The pcDNA3-HA-Elk-1 plasmid encoding HA-Elk-1 fusion protein was used for stable transfection of REF52 cells and E1A+ras transformants. Populations of clones were obtained. Extracts from serumstarved (7) and serum-stimulated for 30 or 120 min were used for immunoprecipitation with antibody to hemagglutinin (HA) cluster. The immunoprecipitates were washed by lysis buer, resolved in 10% polyacrylamide gel, blotted and visualized by antibody to HDAC1 staining with anti-pERK1/2 and anti p-MEK1/2 (Morgan et al., 2001) .
Low level of c-fos transcription in E1A+cHa-ras transformed cells with elevated ERK kinase activity can be provided by formation of inactive structure of c-fos promoter-bound nucleosome due to recruiting the histone deacetylase activity. Consistently, pretreatment with histone deacetylase inhibitor trichostatin A (Alberts et al., 1998) , transfection of exogenous p300 expression vector conferring additional HAT activity (Abramova et al., 2002) or serum-stimulation (Alberts et al., 1998) may cause histone acetylation. There is evidence that the transcription of a number of genes, including the immediate early genes, requires a modi®cation of chromatin structure in promoter region in addition to activation of MAP kinase pathways. Promoters of repressed genes was shown to be associated with histone deacetylase activity (HDAC) and have underor non-acetylated core histones providing inactive nucleosome structure which is not competent for transcription (Grunstein, 1997; Kouzarides, 1999) . Inhibitors of histone deacetylase activity (sodium butyrate, trichostatin A) have been shown to promote transcription of genes regulated through p53, Rb, E2F and other transcription factors (Alberts et al., 1998; Murphy et al., 1999; Luo et al., 1998; Lavarone and Massague, 1999; Sasaki et al., 1999) . Transcription factors like Elk-1 are shown to interact with p300/CBP co-activators that have intrinsic histone acetyl-transferase activity (Ogryzko et al., 1996; Alberts et al., 1998) . Consistently, if c-fos downregulation is mediated via HDAC-induced chromatin inactivation, suppression of the HDAC activity relieves the repression of c-fos transcription in E1A+cHa-ras cells.
Whatever the mechanism of sustained MAP kinase activity and persistent phosphorylation of Elk-1 in E1A+cHa-ras cells, the question of which events trigger the recruitment of HDAC activity to the c-fos promoter-bound nucleosome remains to be investigated. The presence of E1A oncoproducts is not an obstacle for that because in cells transformed by single ras oncogene c-fos is downmodulated (Yu et al., 1993; Mechta et al., 1997) . Our unpublished data on transient transfection of GAL-Elk-1 constructs into REF52 and E1A+cHa-ras cells treated with sodium butyrate and then with PD98059 or SB203580 inhibitors showed that the activatory eect of sodium butyrate was mediated predominantly through MEK/ERK kinase pathway (manuscript in preparation). We suggest that high level of prior Elk-1 phosphorylation is a prerequisite for binding HDAC activity to the c-fos promoter. It has been recently supposed that TCF bound to SRE mediates to some extent negative regulation of the c-fos gene through histone de-acetylation (Criqui-Filipe et al., 1999) . While this paper was under review, Yang et al. (2001) reported that N-terminal part of Elk-1 could associate with HDAC1 through mSin3A protein in vitro.
Materials and methods

Cells
Cells REF, REF52, HeLa and E1A+cHa-ras transformants were grown in DMEM with 10% FCS (Gibco). Cells were serum starved in 0.1 ± 0.5% FCS for 24 ± 48 h, then stimulated by 10% FCS for dierent time. Cells were treated with 0.5 mM okadaic acid (Sigma) for 1 h, with 10 mM sodium butyrate (Sigma) for 6 h.
Immunoblotting and immunoprecipitation
For immunoblotting, cell lysates were obtained in RIPA buer containing PBS solution, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitors (1 mM PMSF, leupeptin, pepstatin A, aprotinin in concentration 10 mg/ml) and phosphatase inhibitors (1 mM sodium vanadate, 5 mM EGTA, 10 mM NaF). Protein concentration was measured by method of Bradford (1976) . Proteins were separated in 10% polyacrylamide gels and blotted on Immobilon-P membranes (Millipore).
Colored proteins manufactured by Novex have been used as molecular weight markers. The following antibodies were used: to non-phosphorylated kinase forms ERK1 (sc-94), JNK1 (sc-571), p38 (sc-535); to phosphorylated kinase forms pERK (sc-7383, pTyr204), pJNK (sc-6254), pp38 (sc-7973, pTyr182); to pElk-1 (sc-8406, pSer-383) (Santa Cruz Biotech); polyclonal antibodies (antisera) to Elk-1, Sap-1, Net, and Net-b proteins (a gift of B Wasylyk); antibodies to hemagglutinin (Boehringer Mannheim) and HDAC1 (06-720, Upstate Biotech.). Polyclonal antibodies to Elk-1 and Sap-1 proteins have also been obtained by immunization of rabbits with GST-Elk1-C or GST-Sap1-C fusion proteins with subsequent puri®cation of the antibodies on Protein GSepharose (Pharmacia). Goat anti-rabbit, rabbit anti-mouse and donkey anti-goat antibodies conjugated with HRP (Sigma) were used as second antibodies. Proteins on membranes were visualized by means of ECL kit (Sigma) or SuperSignal West Femto Maximum Sensitivity Substrate (Pierce).
For immunoprecipitation, cells were lysed in buer containing 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5% NP-40, 1% Triton X-100, protease and phosphatase inhibitors (Malashicheva et al., 2000) . Immunoprecipitation was conducted during 2 h or overnight (for antibody to HA) at 48C (500 ug of cell extract/ug of antibody), the complexes were collected on Protein A-Sepharose beads (Sigma). Kinases associated with Jun, ATF2 and MEF2A were adsorbed with appropriate GST-fusion proteins bound to Glutathione-Sepharose (Pharmacia) (solid assay).
In vitro kinase assay
After washing the bound kinases, the activity was determined in a kinase buer in the presence of 20 mM MgCl2, 2 mM MnCl2, 25 uM ATP (Sigma), 5 uCi of 32 P-g-ATP and substrates: GST-Elk1-C, GST-Jun, GST-ATF2, GST-MEF2A.
RT ± PCR
Total cellular RNA was isolated by a guanidine-isothiocyanate procedure (Chomczynski and Sacchi, 1987) . RT-step was conducted with 3 ug of RNA and 1 ug of random hexaprimers (Pharmacia). The amount of total RNA for RT-reactions was normalized by densitometry of 18S ribosomal RNA after electrophoresis in denaturing agarose gel. PCR-step was performed in the presence of 100 ng of primers to the cDNA of rat c-fos gene: 5'-CTCTAGTGCCA-ACTTTATCC-3'/5'-CTTCAAGTTGATCTGTCTCC-3' and included necessary components. The PCR reaction proceeded 25 ± 30 cycles: denaturation step at 958C ± 1 min, annealing step at 568C ± 1 min, elongation step at 728C ± 2 min. PCRproduct (356 bp) was resolved by electrophoresis in 2% agarose gel. Rat GAPDH gene was selected as an internal control in PCR assay with primers (5'-TGTGATGGGTGT-GAACCACG-3'/5'-CCAGTGAGCTTCCCGTTCAG-3') giving a 297 bp DNA fragment.
Nuclear extracts and gel retardation (EMSA)
Nuclear extracts were obtained according to a protocol of Schreiber (Schreiber et al., 1989) in the presence of 0.6 M NaCl and protease and phosphatase inhibitors. Gel retardation assay performed basically as described (Giovane et al., 1997) . Reaction contained 5 mM HEPES-KOH buer pH 7.9, 75 ± 100 mM NaCl, 2.5 mM DTT, 2.5 mM EDTA, 2.5 mM MgCl2, 15% glycerol, 2 mM spermidine, 2.5 ug of polydI/polydC (Pharmacia), 0.25 ug of salmon sperm DNA, 10 ug of nuclear extracts. The mixture was incubated at 208C for 30 min, then labeled SRE oligonucleotide was added and incubation continued for another 30 min. SRE oligonucleotide from human c-fos gene promoter has following sequence: 5'-CACAGGATGTCCATATTAGGAC-3'. For`supershift' analysis, antibodies (1 ul) were added before the labeled SRE oligonucleotide. DNA-protein complexes were resolved by electrophoresis in 4% gel using 12.5 mM Tris-glycine buer.
